Back to SQNM Stock Lookup

SQNM Related Analyst Ratings

May 31, 2013 07:22 AM Jefferies Assumes Sequenom (SQNM) at Buy

May 13, 2013 06:48 AM Credit Suisse Upgrades Sequenom (SQNM) to Neutral

Apr 4, 2013 09:14 AM UPDATE: Wedbush Upgrades Sequenom (SQNM) to Outperform, Reg. Fears 'Unrealistic'

Mar 1, 2013 06:58 AM Piper Jaffray Upgrades Sequenom (SQNM) to Overweight

Jan 7, 2013 09:45 AM Illumina (ILMN) Will Require 'Significant Investment' to Compete with Sequenom (SQNM)

Nov 26, 2012 08:08 AM Stephens Upgrades Sequenom (SQNM) to Overweight

Nov 21, 2012 09:39 AM Sequenom (SQNM) Higher on ACOG Opionion

Nov 12, 2012 07:02 AM Jefferies Upgrades Sequenom (SQNM) to Buy, 'Cash on the Way'

Sep 25, 2012 06:55 AM Credit Suisse Starts Sequenom (SQNM) at Underperform

Sep 24, 2012 06:51 AM Piper Jaffray Downgrades Sequenom (SQNM) to Neutral

Sep 11, 2012 10:44 AM Dougherty & Co Reiterates a 'Buy' on Sequenom (SQNM); Confidence in Roll-Out of MaterniT21 Test

Jun 19, 2012 08:32 AM Maxim Group Starts Sequenom (SQNM) at Buy

May 18, 2012 10:49 AM Auriga Securities on Sequenom (SQNM): Coventry (CVH) Giveth, Coventry Taketh Away

Apr 24, 2012 08:38 AM Wedbush Upgrades Sequenom (SQNM) to Neutral; Limited Near-Term Negative Catalysts

Apr 23, 2012 02:54 PM Barclays on U.S. Diagnostics: Q1 Earnings Preview

Mar 8, 2012 10:22 AM Auriga Maintains a 'Buy' on Sequenom (SQNM); MaterniT21 off to a Good Start

Jan 30, 2012 10:16 AM Auriga Reiterates a 'Buy' on Sequenom (SQNM); Raising Estimated T21 Test Volumes for 2012

Jan 5, 2012 01:49 PM Dougherty & Co Starts Sequenom (SQNM) at Buy; See MaterniT21 Becoming the New Gold Standard of Care in Down Syndrome Testing

Jan 3, 2012 07:32 AM Piper Jaffray Upgrades Sequenom (SQNM) to Overweight

Nov 15, 2011 01:46 PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Analyst Day Sets Initial T21 Expectations

Oct 18, 2011 01:32 PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); MaterniT21 Launches with Publication of Validation Study Results

Oct 18, 2011 07:17 AM Piper Jaffray Downgrades Sequenom (SQNM) to Neutral

Oct 17, 2011 02:50 PM Barclays on U.S. Diagnostics: Policy, Macro Overhang Persists in Q3

Sep 28, 2011 01:01 PM Barclays Reiterates an 'Overweight' on Sequenom (SQNM); Management Meeting Takeaways

Aug 26, 2011 07:29 AM William Blair Starts Sequenom (SQNM) at Outperform

Aug 5, 2011 07:33 AM Auriga Reiterates a 'Buy' on Sequenom (SQNM); T-21 Manuscript Submitted; Key Timelines Remain On Track

Jul 19, 2011 01:57 PM Barclays on U.S. Diagnostics: Q2 Preview; 2H Volume Recovery Likely Slower Than Expected

Jul 7, 2011 02:02 PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Lo Publishes Data on T-13/T-18 Detection

May 6, 2011 07:08 AM Auriga Rates Sequenom (SQNM) at Buy

Apr 11, 2011 02:43 PM Barclays on U.S. Diagnostics: Q1 2011 Preview

Mar 16, 2011 05:30 PM Oppenheimer Starts (SQNM), (GNOM), (CPHD) at Outperform, (MYGN), (AFFX), (GPRO), (PACB) at Perform

Mar 11, 2011 08:51 AM Jefferies Resumes Coverage on Sequenom (SQNM) at Hold, Price Target $7

Mar 9, 2011 01:27 PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Q4 Review: T21 on Track, Cash Adequate

Mar 9, 2011 08:31 AM Auriga Lowers Price Target on Sequenom (SQNM) But Keeps Buy Ahead of Coming "Data Storm"

Feb 11, 2011 07:05 AM Rodman & Renshaw Upgrades Sequenom (SQNM) to Market Perform

Jan 13, 2011 01:20 PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Dennis Lo's Data Reads Out As Expected

Dec 23, 2010 08:07 AM Soleil Lifts Price Target on Sequenom (SQNM) from $8 to $10

Dec 13, 2010 08:36 AM Piper Jaffray Starts Sequenom (SQNM) at Overweight, $8 Price Target

Dec 3, 2010 01:45 PM Rodman & Renshaw Cuts Sequenom (SQNM) to Market Underperform, Cites Valuation, Limited Newsflow

Nov 22, 2010 12:58 PM Sequenom (SQNM) Shares on the Move as Stephens Issues Mid-Day Upgrade

Aug 4, 2010 07:51 AM Soleil Securities Upgrades Sequenom (SQNM) to Buy

Jul 21, 2010 08:51 AM Sequenom (SQNM) Shares Sharply Higher as Ladenburg Raises to Buy, Sets $8 Price Target

Jul 21, 2010 08:30 AM Jefferies & Co Initiates Coverage on Sequenom (SQNM) with a Hold

Jul 14, 2010 07:37 AM Auriga Reiterates Bullish Stance On Sequenom (SQNM) On Commercial Viability of T21 test

Jun 11, 2010 06:50 AM Auriga Upgrades Sequenom (SQNM) to Buy

May 24, 2010 09:00 AM Sequenom (SQNM): Bullish on the technology and Sequenom's prospects for commercializing T-21 in 2011 - Barclays

May 13, 2010 01:46 PM Wedbush Reaffirms Underperform on Sequenom (SQNM); Current Market Cap Prices In Significant Diagnostics Success

Apr 28, 2010 09:33 AM Global Hunter Thinks Sequenom (SQNM) T21 Restart is On Track, Ups to 'Buy'

Apr 28, 2010 08:42 AM Sequenom (SQNM) Shares Rallying Amid Global Hunter's Upgrade to Buy

Apr 7, 2010 09:28 AM Wedbush Initiates Coverage on Sequenom (SQNM) with an Underperform; RNA Based Test as Good as Dead; Zero Data on DNA-based

Back to SQNM Stock Lookup